Cd-1 Mice
Cd-1 Mice - Related Videos
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
0 Views •
Cited by 21 •
2013
We provide a reproducible method to induce type 1 diabetes (T1D) in mice within two weeks by the adoptive transfer of islet antigen-specific, primary CD4+ T cells.
06:48
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
0 Views •
Cited by 10 •
2014
Tail-skin transplantation is a powerful model for studying T cell-dependent rejection and tolerance induction during allogeneic immune responses in mice. The advantages of this protocol are minor invasive surgery, and ease of monitoring with no need to sacrifice the recipient mouse.
02:40
Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells
0 Views •
2025
This video demonstrates a method of converting dendritic cells (DCs) to tolerogenic DCs (TolDCs) using an immunomodulatory pharmacological agent. This conversion is confirmed by evaluating the TolDC function through their immunosuppressive effect on CD4+ T cells.
11:28
Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis
0 Views •
Cited by 11 •
2016
The mechanisms that govern the interstitial motility of CD4 effector T cells at sites of inflammation are relatively unknown. We present a non-invasive approach to visualize and manipulate in vitro-primed CD4 T cells in the inflamed ear dermis, allowing for study of the dynamic behavior of these cells in situ.
08:20
In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
0 Views •
Cited by 24 •
2016
This protocol describes the reproducible generation and phenotyping of human induced regulatory T cells (iTregs) from naïve CD4+ T cells in vitro. Different protocols for FOXP3 induction allow for the study of specific iTreg phenotypes obtained with respective protocols.
FAQs
Genetic heterogeneity creates a wider range of naturally occurring traits and treatment responses among individual mice. This variation can help researchers examine whether an observed effect remains evident across different biological backgrounds rather than appearing only in genetically uniform animals. Consequently, findings from Cd-1 mice may offer broader population-level relevance, particularly when human genetic diversity is an important consideration.
Cd-1 mice generally show more variability between individuals because they retain greater genetic diversity, whereas inbred strains provide greater genetic uniformity. This distinction changes how researchers interpret results: consistent responses in Cd-1 mice may support broader generalizability, while variable responses require attention to the range of outcomes rather than relying only on a single average value.
Natural phenotypic variation can make treatment effects harder to distinguish from differences that already exist among individual animals. Larger groups may help researchers separate these sources of variation and characterize the spread of responses more reliably. Careful experimental design remains essential, because increased sample size alone does not eliminate biological diversity or clarify an effect without appropriate interpretation.
Cd-1 mice are useful when investigators need to study responses across genetically diverse animals. Their applications include toxicology, pharmacology, reproductive biology, developmental research, and general disease investigations. In these settings, the stock can help reveal whether biological or treatment-related effects occur across a broader range of genetic backgrounds, supporting medical research that seeks relevance beyond a uniform laboratory population.
Variable responses should be evaluated as a combination of possible treatment effects and natural differences among animals. Researchers need experimental designs that can distinguish these influences and should consider the range of observed phenotypes, not only the group average. This approach is particularly important when assessing medicines, toxic exposures, or disease-related outcomes in genetically diverse populations.
Cd-1 mice can support questions about how genetic diversity influences toxicity, drug responses, reproduction, development, and disease-related traits. Their use is most informative when population-level variation is relevant to the research goal. By exposing a study to broader biological heterogeneity, they can help investigators identify responses that may be more representative of genetically variable populations.